Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 4:15 pm Purchase |
2025-04-15 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 205,465 2.200% |
205,465 (New Position) |
Filing History |
| 2024-12-18 5:10 pm Unchanged |
2024-12-17 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 616,398 13.500% |
0 (Unchanged) |
Filing History |
| 2024-10-30 4:21 pm Unchanged |
2024-10-23 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 616,398 13.500% |
0 (Unchanged) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Cara Therapeutics, Inc. CARA |
BLACKROCK INC BLK |
62,059 1.400% |
-234,129 (-79.05%) |
Filing History |
| 2024-02-13 6:50 pm Sale |
2023-12-31 | 13G | Cara Therapeutics, Inc. CARA |
Bain Capital Life Sciences Opportunities III, LP | 0 0.000% |
-224,669 (Position Closed) |
Filing History |
| 2024-02-13 5:01 pm Sale |
2023-12-29 | 13G | Cara Therapeutics, Inc. CARA |
The Vanguard Group | 219,256 4.830% |
-39,221 (-15.17%) |
Filing History |
| 2024-01-29 3:26 pm Sale |
2023-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BLACKROCK INC BLK |
296,188 6.500% |
-12,309 (-3.99%) |
Filing History |
| 2023-07-25 4:40 pm Unchanged |
2023-07-25 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 616,398 13.700% |
0 (Unchanged) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Cara Therapeutics, Inc. CARA |
BLACKROCK INC BLK |
308,497 6.900% |
-335,713 (-52.11%) |
Filing History |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Cara Therapeutics, Inc. CARA |
The Vanguard Group | 258,477 5.770% |
5,747 (+2.27%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BLACKROCK INC BLK |
644,211 14.400% |
0 (Unchanged) |
Filing History |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BLACKROCK INC BLK |
644,211 14.400% |
44,284 (+7.38%) |
Filing History |
| 2022-11-18 4:16 pm Purchase |
2022-11-09 | 13G | Cara Therapeutics, Inc. CARA |
Bain Capital Life Sciences Opportunities III, LP | 224,669 5.000% |
224,669 (New Position) |
Filing History |
| 2022-02-14 6:16 pm Sale |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
FIRST MANHATTAN CO | 0 0.000% |
-267,733 (Position Closed) |
Filing History |
| 2022-02-14 11:35 am Sale |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
RHO Ventures VI LP | 65 0.000% |
-233,190 (-99.97%) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
The Vanguard Group | 252,730 5.670% |
252,730 (New Position) |
Filing History |
| 2022-01-28 1:54 pm Sale |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BLACKROCK INC BLK |
599,927 13.500% |
-2,929 (-0.49%) |
Filing History |
| 2021-10-21 4:15 pm Purchase |
2021-10-20 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 616,398 13.900% |
273,533 (+79.78%) |
Filing History |
| 2021-05-07 5:09 pm Purchase |
2021-04-30 | 13G | Cara Therapeutics, Inc. CARA |
BLACKROCK INC BLK |
602,856 14.500% |
300,168 (+99.17%) |
Filing History |
| 2021-02-16 2:41 pm Purchase |
2020-12-31 | 13G | Cara Therapeutics, Inc. CARA |
FIRST MANHATTAN CO | 267,733 6.450% |
267,733 (New Position) |
Filing History |